Market Cap | 188.88B | P/E | 33.02 | EPS this Y | 5.00% | Ern Qtrly Grth | -5.30% |
Income | 5.54B | Forward P/E | 23.51 | EPS next Y | 10.30% | 50D Avg Chg | 2.00% |
Sales | 40.73B | PEG | 2.97 | EPS past 5Y | 7.17% | 200D Avg Chg | 3.00% |
Dividend | 2.00% | Price/Book | 5.10 | EPS next 5Y | 8.20% | 52W High Chg | -6.00% |
Recommedations | 2.00 | Quick Ratio | 1.02 | Shares Outstanding | 1.74B | 52W Low Chg | 16.00% |
Insider Own | 0.53% | ROA | 6.26% | Shares Float | 1.73B | Beta | 0.72 |
Inst Own | 77.49% | ROE | 14.44% | Shares Shorted/Prior | 13.36M/12.68M | Price | 108.62 |
Gross Margin | 55.48% | Profit Margin | 13.65% | Avg. Volume | 4,711,008 | Target Price | 124.53 |
Oper. Margin | 17.66% | Earnings Date | Oct 16 | Volume | 4,699,325 | Change | -1.73% |
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Evercore ISI Group | Outperform | Oct 1, 24 |
Jefferies | Hold | Sep 26, 24 |
Piper Sandler | Overweight | Sep 19, 24 |
Jefferies | Buy | Aug 27, 24 |
Citigroup | Buy | Aug 22, 24 |
Barclays | Overweight | Jul 29, 24 |
Evercore ISI Group | Outperform | Jul 2, 24 |
RBC Capital | Outperform | Jun 4, 24 |
Goldman Sachs | Buy | May 30, 24 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
Wainer Andrea F | EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT | Jan 29 | Sell | 112.5 | 42,500 | 4,781,250 | 65,027 | 01/31/24 |
Wainer Andrea F | EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT | Jan 29 | Option | 52.17 | 42,500 | 2,217,225 | 82,527 | 01/31/24 |
Wainer Andrea F | EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT | Dec 14 | Sell | 108 | 15,000 | 1,620,000 | 65,027 | 12/18/23 |
Wainer Andrea F | EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT | Dec 14 | Option | 44.4 | 15,000 | 666,000 | 80,027 | 12/18/23 |
Wainer Andrea F | EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT | Aug 08 | Sell | 105.95 | 10,400 | 1,101,880 | 65,027 | 08/10/23 |
Wainer Andrea F | EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT | Aug 08 | Option | 38.4 | 5,000 | 192,000 | 75,427 | 08/10/23 |
STARKS DANIEL J | Director Director | Jul 27 | Sell | 113.72 | 50,000 | 5,686,000 | 6,775,316 | 07/28/23 |
Wainer Andrea F | EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT | May 02 | Sell | 110.56 | 8,226 | 909,467 | 70,427 | 05/03/23 |
Wainer Andrea F | EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT | May 02 | Option | 47 | 8,226 | 386,622 | 78,653 | 05/03/23 |
STARKS DANIEL J | Director Director | Apr 28 | Sell | 111.36 | 50,000 | 5,568,000 | 6,825,316 | 05/02/23 |
WOODGRIFT RANDEL WILLIAM | SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT | Feb 28 | Sell | 100.7 | 1,032 | 103,922 | 52,203 | 03/02/23 |
Morrone Louis H. | SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT | Feb 28 | Sell | 100.7 | 1,092 | 109,964 | 53,656 | 03/02/23 |
Moreland Mary K | EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT | Feb 28 | Sell | 100.77 | 717 | 72,252 | 87,224 | 03/02/23 |
MANNING JOSEPH J | EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT | Feb 28 | Sell | 100.7 | 1,339 | 134,837 | 62,323 | 03/02/23 |
Ginascol John F | EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT | Feb 28 | Sell | 100.7 | 943 | 94,960 | 118,380 | 03/02/23 |
Funck, Jr. Robert E. | EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT | Feb 28 | Sell | 100.7 | 1,264 | 127,285 | 218,237 | 03/02/23 |
Earnhardt Lisa D | EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT | Feb 28 | Sell | 100.7 | 943 | 94,960 | 75,437 | 03/02/23 |
DALE MICHAEL D | SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT | Feb 28 | Sell | 100.7 | 1,209 | 121,746 | 45,133 | 03/02/23 |
ALLEN HUBERT L | EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT | Feb 28 | Sell | 100.7 | 1,069 | 107,648 | 175,959 | 03/02/23 |
Ahlberg Gregory A | SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT | Feb 28 | Sell | 100.7 | 1,317 | 132,622 | 38,420 | 03/02/23 |
Karam Sammy | SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT | Dec 29 | Sell | 108.75 | 4,200 | 456,750 | 26,462 | 01/03/23 |
Ginascol John F | EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT | Dec 13 | Sell | 112.32 | 11,000 | 1,235,520 | 111,912 | 12/15/22 |
STARKS DANIEL J | Director Director | Oct 27 | Sell | 97.72 | 50,000 | 4,886,000 | 6,873,500 | 10/31/22 |
MANNING JOSEPH J | EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT | Sep 08 | Option | 44.4 | 23,008 | 1,021,555 | 76,253 | 09/09/22 |
MANNING JOSEPH J | EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT | Sep 08 | Sell | 107 | 23,008 | 2,461,856 | 53,245 | 09/09/22 |
Ford Robert B | CHAIRMAN AND CEO CHAIRMAN AND CEO | Aug 25 | Option | 40.13 | 102,425 | 4,110,315 | 244,496 | 08/26/22 |
Ford Robert B | CHAIRMAN AND CEO CHAIRMAN AND CEO | Aug 25 | Sell | 105.1 | 102,425 | 10,764,868 | 142,071 | 08/26/22 |
MANNING JOSEPH J | EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT | Aug 25 | Option | 44.4 | 23,008 | 1,021,555 | 80,143 | 08/26/22 |
MANNING JOSEPH J | EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT | Aug 25 | Sell | 105.12 | 26,898 | 2,827,518 | 53,245 | 08/26/22 |
STARKS DANIEL J | Director Director | Jul 26 | Sell | 109.19 | 50,000 | 5,459,500 | 6,923,500 | 07/28/22 |
Mateus Fernando | SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT | Jul 26 | Sell | 109.0529 | 2,457 | 267,943 | 14,503 | 07/27/22 |
Tyler Julie L. | SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT | Jul 25 | Sell | 109.09 | 253 | 27,600 | 33,868 | 07/27/22 |
WOODGRIFT RANDEL WILLIAM | SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT | May 04 | Option | 44.4 | 24,000 | 1,065,600 | 71,854 | 05/05/22 |
WOODGRIFT RANDEL WILLIAM | SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT | May 04 | Sell | 113 | 24,000 | 2,712,000 | 47,854 | 05/05/22 |
STARKS DANIEL J | Director Director | May 03 | Sell | 113.55 | 50,000 | 5,677,500 | 6,973,500 | 05/05/22 |
DALE MICHAEL D | SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT | Mar 08 | Sell | 117.0003 | 4,000 | 468,001 | 41,780 | 03/10/22 |
WOODGRIFT RANDEL WILLIAM | SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT | Feb 28 | Sell | 118.1 | 964 | 113,848 | 49,223 | 03/02/22 |
Watkin Jared | SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT | Feb 28 | Sell | 118.1 | 1,038 | 122,588 | 66,545 | 03/02/22 |
Wainer Andrea F | EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT | Feb 28 | Sell | 118.13 | 456 | 53,867 | 62,172 | 03/02/22 |
Salvadori Daniel Gesua Sive | EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT | Feb 28 | Sell | 118.17 | 1,550 | 183,164 | 112,248 | 03/02/22 |
Morrone Louis H. | SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT | Feb 28 | Sell | 118.16 | 656 | 77,513 | 47,278 | 03/02/22 |
MANNING JOSEPH J | EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT | Feb 28 | Sell | 118.16 | 779 | 92,047 | 60,873 | 03/02/22 |
Ginascol John F | EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT | Feb 28 | Sell | 118.16 | 365 | 43,128 | 124,680 | 03/02/22 |
Earnhardt Lisa D | EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT | Feb 28 | Sell | 118.15 | 943 | 111,415 | 90,630 | 03/02/22 |
DALE MICHAEL D | SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT | Feb 28 | Sell | 118.15 | 1,053 | 124,412 | 45,780 | 03/02/22 |
Calamari Christopher J. | SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT | Feb 28 | Sell | 118.15 | 706 | 83,414 | 25,658 | 03/02/22 |
ALLEN HUBERT L | EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT | Feb 28 | Sell | 118.17 | 1,450 | 171,346 | 167,095 | 03/02/22 |
Ahlberg Gregory A | SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT | Feb 28 | Sell | 118.15 | 1,099 | 129,847 | 33,274 | 03/02/22 |
McKinstry Nancy | Director Director | Feb 24 | Option | 29.84 | 6,280 | 187,395 | 33,419 | 02/25/22 |
McKinstry Nancy | Director Director | Feb 24 | Sell | 116.43 | 1,614 | 187,918 | 31,805 | 02/25/22 |